NEW WHITE PAPER:  Solving Atypical Protein Expression with Transposase Technology    Dive in today!
Contact Us
Contact Us

AGC Biologics

AGC Biologics Yokohama Facility begins GMP production in 2027

2 min read

AGC Biologics Strengthens Single-Use Technology Network, Adds 5,000 L Vessels from Thermo Scientific to New Yokohama, Japan Facility

April 7, 2025 at 3:51 PM
Mammalian & mAbs Press Release
Read press release
AGC Biologics announces new cell and gene business division

3 min read

AGC Biologics Launches New Dedicated Cell and Gene Business Division

April 2, 2025 at 12:25 PM
Cell & Gene Therapy Press Release
Read press release

1 min read

AGC Biologics Honored at CDMO Leadership Awards for Excellence in Quality, Biologics and Cell and Gene Therapies

March 10, 2025 at 2:41 PM
Cell & Gene Therapy Mammalian & mAbs Press Release Microbial
Read press release
Adaptimmune and AGC Biologics Partnership

2 min read

AGC Biologics’ Milan Site to Prepare Lentiviral Vector Commercial Manufacturing for Adaptimmune’s Lete-Cel Product

January 16, 2025 at 5:30 AM
Cell & Gene Therapy Press Release
Read press release
AGC Biologics’ Cell and Gene Center of Excellence expands exosome work with new project.

2 min read

Pandorum Partners with AGC Biologics to Support Clinical Manufacturing of Exosome-Based Kuragenx, a Treatment of Ulcerative Corneal Blindness

January 9, 2025 at 7:00 AM
Cell & Gene Therapy Press Release
Read press release
New leadership roles to drive operational readiness and regional growth for the company in Japan

1 min read

AGC Biologics Announces Leadership Updates Amid Groundbreaking of New Yokohama Site

December 22, 2024 at 6:00 PM
Press Release Business Updates
Read press release
AGC Biologics CMC Jumpstart™ Program Offers Platform Assessments

2 min read

New AGC Biologics CMC Jumpstart™ Program Offers CGT Developers Viral Vector Platform Assessments that Control Costs and Analyze Feasibility

December 18, 2024 at 9:15 AM
Cell & Gene Therapy Press Release
Read press release
Autolus and AGC Biologics

2 min read

AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL®

December 11, 2024 at 9:00 AM
Cell & Gene Therapy Press Release
Read press release

2 min read

AGC Biologics Appoints Alberto Santagostino as new Chief Executive Officer

October 28, 2024 at 3:00 AM
Press Release Business Updates
Read press release
Seattle BLAs - 3 approvals in 2024

1 min read

AGC Biologics Seattle Achieves Approval for all 2024 Biologics License Applications from U.S. Food and Drug Administration, Concluding Pre-License Inspection

October 17, 2024 at 3:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
Prev 1 2 3 4 5 Next